Drug · DIN 01926551
SECTRAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 9, 2018; first marketed December 31, 1986.
- Drug Identification Number (DIN)
- 01926551
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Acebutolol C07AB04
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACEBUTOLOL (ACEBUTOLOL HYDROCHLORIDE) | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 17, 2006: NOC 7832New Drug Submission (NDS) · Manufacturer name change
- November 14, 2000: NOC 940New Drug Submission (NDS)
Other DINs named SECTRAL
- DIN 01926543 · Cancelled Post Market
- DIN 01926578 · Cancelled Post Market